Androgen therapy.
D045930:Anabolic Agents / Q000627:therapeutic use*; D000728:Androgens / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D000731:Androstanes / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy; D002979:Climacteric; D005260:Female; D005474:Fluoxymesterone / Q000627:therapeutic use; D006402:Hematologic Diseases / Q000188:drug therapy; D006801:Humans; D007018:Hypopituitarism / Q000188:drug therapy; D008297:Male; D008777:Methyltestosterone / Q000627:therapeutic use; D013733:Testicular Diseases / Q000188:drug therapy; D013737:Testis / Q000254:growth & development; D013739:Testosterone / Q000502:physiology
D045930:Anabolic Agents; D000728:Androgens; D000731:Androstanes; D013739:Testosterone; D005474:Fluoxymesterone; D008777:Methyltestosterone